Augmentin 875/125 mg is the appropriate adult formulation for this 16-year-old patient weighing 121.9 kg
For a 16-year-old weighing 121.9 kg, use the adult dosing of Augmentin 875 mg/125 mg twice daily rather than pediatric weight-based dosing. This patient has reached adult body size and should be dosed according to adult recommendations 1.
Key Dosing Principles
When to Transition to Adult Dosing
The FDA label explicitly states that pediatric patients weighing 40 kg or more should be dosed according to adult recommendations 1. At 121.9 kg, this patient is well above this threshold and clearly qualifies for adult dosing.
Standard Adult Augmentin Regimens
For adults, the FDA-approved dosing options are 1:
- 500 mg/125 mg every 8 hours (standard dosing)
- 875 mg/125 mg every 12 hours (preferred for convenience and compliance)
The 875/125 mg twice-daily formulation is specifically designed for adult use and provides equivalent efficacy to the three-times-daily 500/125 mg regimen 2, 3. Clinical trials demonstrate that the 875/125 mg BID dosing achieves similar clinical success rates (93-94%) as 500/125 mg TID for respiratory tract infections, with the added benefit of improved compliance and potentially less diarrhea 2.
Why Not Pediatric Weight-Based Dosing?
The pediatric guidelines you referenced [4-4] recommend amoxicillin-clavulanate at 45 mg/kg/day in 3 doses or 90 mg/kg/day in 2 doses for β-lactamase-producing organisms. However, these guidelines include a critical caveat: "Doses for oral therapy should not exceed adult doses" 4.
If you were to calculate 45 mg/kg/day for this 121.9 kg patient, you would get 5,485 mg/day of amoxicillin—far exceeding the maximum adult dose of 1,750 mg/day (875 mg BID). This would be inappropriate and potentially unsafe.
Clinical Context Matters
For Most Infections
The 875/125 mg twice daily formulation is appropriate for:
- Respiratory tract infections (sinusitis, pneumonia, bronchitis)
- Skin and soft tissue infections
- Most moderate-severity infections
For Severe Infections
If treating a more severe infection, consider:
- 500/125 mg three times daily for higher total daily amoxicillin exposure (1,500 mg vs 1,750 mg)
- Though recent evidence suggests the BID regimen may be equally effective even for severe infections 2
Common Pitfalls to Avoid
Do not use two 250/125 mg tablets to substitute for one 500/125 mg tablet - they contain different amounts of clavulanate and are not interchangeable 1
Do not apply pediatric weight-based dosing beyond 40 kg - this leads to excessive and potentially unsafe doses
Do not use Augmentin ES-600 suspension - this pediatric formulation is not intended for patients of this size and has no adult dosing data 5
Consider obesity-related pharmacokinetics - While this patient is overweight, recent evidence suggests standard adult dosing of amoxicillin-clavulanate achieves adequate drug exposure in patients with obesity, with most reaching pharmacokinetic targets at 1000 mg/200 mg IV or 1000 mg/125 mg PO every 8 hours 6. The 875/125 mg BID regimen provides comparable exposure.